Category: Sensorineural

Sensorineural

Latest

Akouos’ AK-OTOF Receives Orphan Drug Designation

Akouos, Inc announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) issued a positive opinion on the company’s application for orphan drug designation for AK-OTOF, a gene therapy intended for the treatment of otoferlin gene-mediated hearing loss. The positive opinion was subsequently adopted by the European Commission.

How Might the Brain Change When We Reintroduce Sound? Interview with Anu Sharma, PhD

New research shows that after wearing professionally fit quality hearing aids, a patient’s brain may “re-organize” its auditory processing centers back towards its original state prior to the hearing loss—with corresponding gains in auditory speech perception abilities and improvements in global cognitive function, executive function, processing speed, and visual working memory performance. Anu Sharma discusses the research findings with Douglas Beck.

Read More

Managing People with Sensorineural and Conductive Unilateral Hearing Loss and Single-Sided Deafness

CROS and BiCROS hearing aids are not the only treatment options for those with unilateral hearing loss. This article reviews other options and potential future avenues for unilateral sensorineural hearing loss and single-sided deafness, as well as for unilateral conductive hearing loss.

Read More

SPECIAL REPORT: Social Engagement and Hearing Loss

Human beings are social creatures. This special report, featuring comments from leading experts in psychology and audiology, reviews new and important research on hearing loss, and shows why audiological care needs to renew its focus on helping patients regain their communication and social engagement activities—those things that make life meaningful and rewarding.

Read More
Loading